← All funded startups

November 3, 2026

Specific Biologics

Biotechnology company advancing gene-editing therapeutic candidates for ALS.

Round: Series A
Amount raised: $35M
Lead investor: —
Industry: Biotechnology
Headquarters: New York
Employees: —
Website: —
LinkedIn: —